Cargando…

Response to Are NKT cells a useful predictor of COVID-19 severity?

Detalles Bibliográficos
Autores principales:	Kreutmair, Stefanie, Becher, Burkhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783200/ https://www.ncbi.nlm.nih.gov/pubmed/35065711 http://dx.doi.org/10.1016/j.immuni.2022.01.012

Ejemplares similares

Are NKT cells a useful predictor of COVID-19 severity?
por: Koay, Hui-Fern, et al.
Publicado: (2022)

Major reduction of NKT cells in patients with severe COVID-19 pneumonia
por: Zingaropoli, Maria Antonella, et al.
Publicado: (2021)

Preexisting comorbidities shape the immune response associated with severe COVID-19
por: Kreutmair, Stefanie, et al.
Publicado: (2022)

NKT Cells in the Induced Sputum of Severe Asthmatics
por: Hamzaoui, Agnes, et al.
Publicado: (2006)

NKT10 cells: a novel iNKT cell subset
por: Wingender, Gerhard, et al.
Publicado: (2015)

NKT Cell Responses to B Cell Lymphoma
por: Li, Junxin, et al.
Publicado: (2014)

S257: CAR T CELLS AND THEIR IMMUNE ENVIRONMENT SHAPE DISTINCT IMMUNE PROFILES IN RESPONSE AND TOXICITY IN B CELL LYMPHOMA PATIENTS
por: Kreutmair, Stefanie, et al.
Publicado: (2023)

Lipid tails dictate NKT cell response
por: Bashyam, Hema
Publicado: (2007)

Dynamics of NKT-Cell Responses to Chlamydial Infection
por: Shekhar, Sudhanshu, et al.
Publicado: (2015)

NKT Cells in Sepsis
por: Leung, Briana, et al.
Publicado: (2010)

Can we define CD3(+)CD56(+) cells as NKT cells with impunity?
por: Lenart, Marzena, et al.
Publicado: (2021)

Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy
por: TANIGUCHI, Masaru, et al.
Publicado: (2015)

Distinct B and NKT cell responses shape the delayed response to ChAdOx1 nCoV-19 vaccine in end-stage renal disease
por: Putri, Denise Utami, et al.
Publicado: (2022)

Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses
por: Fujii, Shin-ichiro, et al.
Publicado: (2018)

Overexpression of RANKL by invariant NKT cells enriched in the bone marrow of patients with multiple myeloma
por: Spanoudakis, E, et al.
Publicado: (2016)

Natural Killer T (NKT) Cells and Periodontitis: Potential Regulatory Role of NKT10 Cells
por: Melgar-Rodríguez, Samanta, et al.
Publicado: (2021)

Role of NKT Cells during Viral Infection and the Development of NKT Cell-Based Nanovaccines
por: Khan, Masood Alam, et al.
Publicado: (2021)

The Transcriptional Repressor Gfi1 Plays a Critical Role in the Development of NKT1- and NKT2-Type iNKT Cells
por: Yasuoka, Toshiaki, et al.
Publicado: (2016)

Viral load at hospitalization is an independent predictor of severe COVID‐19
por: Waller, Hjalmar, et al.
Publicado: (2022)

Elevated NKT cell levels in adults with severe chronic immune thrombocytopenia
por: XU, RUILONG, et al.
Publicado: (2014)

Trouble-making NKT cells
por: Van Epps, Heather L.
Publicado: (2005)

NKT cells depend on SAP
por: Van Epps, Heather L.
Publicado: (2005)

NKT cells reject islets
por: Van Epps, Heather L.
Publicado: (2005)

NKT cells get specialized
por: Van Epps, Heather L.
Publicado: (2005)

NKT Cells in Neurological Diseases
por: Cui, Yu, et al.
Publicado: (2019)

The Role of NKT Cells in Glioblastoma
por: Brettschneider, Emily E. S., et al.
Publicado: (2021)

Harnessing NKT cells for vaccination
por: Burn, Olivia K, et al.
Publicado: (2021)

Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effect
por: Prasit, Kef K, et al.
Publicado: (2022)

Invariant NKT Cell Response to Dengue Virus Infection in Human
por: Matangkasombut, Ponpan, et al.
Publicado: (2014)

CLINICAL PREDICTORS OF RESPONSE TO ECT IN SEVERE DEPRESSION
por: Agrawal, Arun Lata
Publicado: (2001)

Exploiting invariant NKT cells to promote T-cell responses to cancer vaccines
por: Hunn, Martin K., et al.
Publicado: (2013)

The use of procalcitonin as an antimicrobial stewardship tool and a predictor of disease severity in coronavirus disease 2019 (COVID-19)
por: Drewett, George P., et al.
Publicado: (2021)

NKT Cell-TCR Expression Activates Conventional T Cells in Vivo, but Is Largely Dispensable for Mature NKT Cell Biology
por: Vahl, J. Christoph, et al.
Publicado: (2013)

Serum calprotectin is not an independent predictor of severe COVID-19 in ambulatory adult patients
por: Mentzer, Alexander J, et al.
Publicado: (2022)

STAT5B(N642H) drives transformation of NKT cells: a novel mouse model for CD56(+) T-LGL leukemia
por: Klein, Klara, et al.
Publicado: (2019)

Blocking the CD47-SIRPα interaction reverses the disease phenotype in a polycythemia vera mouse model
por: Lysenko, Veronika, et al.
Publicado: (2023)

New ways to turn on NKT cells
por: Godfrey, Dale Ian, et al.
Publicado: (2011)

Role of NKT Cells in the Pathogenesis of NAFLD
por: Tajiri, Kazuto, et al.
Publicado: (2012)

Advances in NKT cell Immunotherapy for Glioblastoma
por: Pyaram, Kalyani, et al.
Publicado: (2018)

Editorial: NKT Cells in Cancer Immunotherapy
por: Webb, Tonya J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_it1ueh40u1snvdh3bldbnmlrf6